Triferic Pediatric Pharmacokinetic Protocol
NCT02595437
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
End Stage Renal Disease
Interventions
DRUG:
Triferic
Sponsor
Rockwell Medical Technologies, Inc.